Marker Therapeutics

Marker Therapeutics: Focused on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. MT-401, its lead MultiTAA-specific T cell product candidate, has received Orphan Drug Designation for the treatment of post-transplant acute myeloid leukemia (AML) and is currently in a Ph 2 study (n=160) evaluating clinical efficacy in both the adjuvant (n=120) and active disease (n=40) setting. Topline results from the active disease group is expected in Q1 2022.
Based in...
US - West South Central
Clinical Stage
Phase l or ll
Disease Space
Biotechnology, Pharmaceuticals
Investement Strategy
Under the Radar
Public, USA
Market Cap
Therapeutic Modalities
Cell Therapy
3200 Southwest Fwy #2240, Phoenix Tower
Houston, TX 77027
United States

Company Participants at Solebury Trout Hamptons CEO Roundtable 2021

  • Peter L. Hoang, President & CEO

Top 10 Holders of Marker Therapeutics, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
NEA Management Co. 12.90 10,714,285 5.79 13F 3/31/22
Aisling Capital Management LP 3.78 3,142,857 1.70 13F 3/31/22
Long Focus Capital Management LLC 2.93 2,435,863 1.32 13F 3/31/22
Wellington Management Co. LLP 2.86 2,378,629 1.28 Funds 9/30/21
The Vanguard Group, Inc. 2.78 2,319,835 1.25 Funds 6/30/22
Vanguard Group, Inc. (Subfiler) 2.75 2,282,168 1.23 13F 3/31/22
Renaissance Technologies LLC 0.70 584,272 0.32 13F 3/31/22
Geode Capital Management LLC 0.70 579,099 0.31 13F 3/31/22
Norges Bank Investment Management 0.53 443,493 0.24 Funds 12/31/21
ACT Capital Management LLC 0.43 354,400 0.19 13F 3/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.